BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27734164)

  • 21. Association between Alzheimer disease and amyotrophic lateral sclerosis?
    Sadovnick AD
    Can J Neurol Sci; 1990 Aug; 17(3):352. PubMed ID: 2207894
    [No Abstract]   [Full Text] [Related]  

  • 22. Ice Bucket Challenge offers invigorating fundraising lessons.
    Landen R
    Mod Healthc; 2014 Sep; 44(35):12. PubMed ID: 25318273
    [No Abstract]   [Full Text] [Related]  

  • 23. Proposed criteria for familial amyotrophic lateral sclerosis.
    Byrne S; Bede P; Elamin M; Kenna K; Lynch C; McLaughlin R; Hardiman O
    Amyotroph Lateral Scler; 2011 May; 12(3):157-9. PubMed ID: 21208036
    [No Abstract]   [Full Text] [Related]  

  • 24. The ALS ice bucket challenge - can a splash of water reinvigorate a field?
    Wicks P
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Dec; 15(7-8):479-80. PubMed ID: 25431828
    [No Abstract]   [Full Text] [Related]  

  • 25. TP53 Arg72Pro polymorphism in Turkish patients with sporadic amyotrophic lateral sclerosis.
    Ergul E; Ozel MD; Sazci A; Idrisoglu HA
    Neurobiol Aging; 2011 Nov; 32(11):2107.e1-2. PubMed ID: 21741128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The RNAs of ALS.
    Thuault S
    Nat Neurosci; 2015 Aug; 18(8):1066. PubMed ID: 26216462
    [No Abstract]   [Full Text] [Related]  

  • 27. Amyotrophic Lateral Sclerosis.
    Brown RH; Al-Chalabi A
    N Engl J Med; 2017 Jul; 377(2):162-172. PubMed ID: 28700839
    [No Abstract]   [Full Text] [Related]  

  • 28. Models of amyotrophic lateral sclerosis.
    Jackson M; Ganel R; Rothstein JD
    Curr Protoc Neurosci; 2002 Nov; Chapter 9():Unit 9.13. PubMed ID: 18428572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monozygotic twins discordant for primary lateral sclerosis.
    Sorenson EJ
    Amyotroph Lateral Scler; 2006 Jun; 7(2):123-5. PubMed ID: 16753978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyotrophic lateral sclerosis: pathogenesis.
    Robberecht W; Van Den Bosch L; Vleminckx V
    Acta Neurol Belg; 2000 Sep; 100(3):181-7. PubMed ID: 11098292
    [No Abstract]   [Full Text] [Related]  

  • 31. Familial amyotrophic lateral sclerosis and Alzheimer's disease. Transgenic models.
    Wong PC; Borchelt DR; Lee MK; Pardo CA; Thinakaran G; Martin LJ; Sisodia SS; Price DL
    Adv Exp Med Biol; 1998; 446():145-59. PubMed ID: 10079842
    [No Abstract]   [Full Text] [Related]  

  • 32. Amyotrophic lateral sclerosis: recent advances in understanding disease mechanisms.
    de Belleroche J; Orrell RW; Virgo L
    J Neuropathol Exp Neurol; 1996 Jul; 55(7):747-57. PubMed ID: 8965091
    [No Abstract]   [Full Text] [Related]  

  • 33. Properties of slow- and fast-twitch muscle fibres in a mouse model of amyotrophic lateral sclerosis.
    Atkin JD; Scott RL; West JM; Lopes E; Quah AK; Cheema SS
    Neuromuscul Disord; 2005 May; 15(5):377-88. PubMed ID: 15833433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyotrophic lateral sclerosis and spinocerebellar ataxia 2.
    Fischbeck KH; Pulst SM
    Neurology; 2011 Jun; 76(24):2050-1. PubMed ID: 21562249
    [No Abstract]   [Full Text] [Related]  

  • 35. ALS mutations in TLS/FUS disrupt target gene expression.
    Coady TH; Manley JL
    Genes Dev; 2015 Aug; 29(16):1696-706. PubMed ID: 26251528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular approaches to amyotrophic lateral sclerosis.
    Smith RG; Appel SH
    Annu Rev Med; 1995; 46():133-45. PubMed ID: 7598450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers.
    Freischmidt A; Müller K; Zondler L; Weydt P; Volk AE; Božič AL; Walter M; Bonin M; Mayer B; von Arnim CA; Otto M; Dieterich C; Holzmann K; Andersen PM; Ludolph AC; Danzer KM; Weishaupt JH
    Brain; 2014 Nov; 137(Pt 11):2938-50. PubMed ID: 25193138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Take the plunge (for charity).
    Nat Med; 2014 Oct; 20(10):1079. PubMed ID: 25295923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Lee JY; Lee JD; Phipps S; Noakes PG; Woodruff TM
    J Neuroinflammation; 2015 May; 12():90. PubMed ID: 25962427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase of disease duration of amyotrophic lateral sclerosis in a mouse model by transgenic small interfering RNA.
    Yokota T; Sasaguri H; Saito Y; Yamada H; Unno T; Yamamoto Y; Kubodera T; Anzai M; Mitani T; Mizusawa H
    Arch Neurol; 2007 Jan; 64(1):145-6. PubMed ID: 17210827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.